Intraoperative radiotherapy (IORT) as boost in breast cancer

75Citations
Citations of this article
111Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The term IORT (intraoperative radiotherapy) is currently used for various techniques that show huge differences in dose delivery and coverage of the tissue at risk. The largest evidence for boost IORT preceding whole breast irradiation (WBI) originates from intraoperative electron treatments (IOERT) with single doses around 10 Gy. At median follow-up periods at 6 years, outstandingly low local recurrence rates of less than 1% are observed. Higher local relapse rates were described for G3 tumors and triple negative breast cancers as well as for IORT following primary systemic treatment for locally advanced tumors. Even there, long term (>5y) local tumor control rates mostly beyond 95% were maintained. Compared to other boost methods, an intraoperative treatment has evident advantages in terms of precision (by avoiding a "spatial and/or temporal miss"), cosmetic outcome and patient comfort. Direct visualisation of a tumor bed during surgery guarantees for an accurate dose delivery, which has additionally gained importance in times of primary reconstruction techniques after lumpectomy, since IORT is performed before breast tissue including parts of the tumor bed is mobilized for plastic purposes. As a consequence of direct tissue exposure without distension by hematoma/seroma, IORT allows for small treatment volumes and complete skin sparing, both having a positive effect on late tissue tolerance and, hence, cosmetic appearance. Boost IORT marginally prolongs the surgical procedure, while significantly shortening postoperative radiotherapy. Its combination with external beam radiotherapy to the whole breast (WBI) is currently tested in two multicentric prospective trials: as kV-IORT in the multicentric TARGIT-B (oost) study, and as IOERT in the HIOB trial (3 weeks hypofractionated WBI preceded by IORT electron boost).

Cited by Powered by Scopus

ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer

65Citations
N/AReaders
Get full text

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward

37Citations
N/AReaders
Get full text

Modern radiotherapy in cancer treatment during pregnancy

36Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sedlmayer, F., Reitsamer, R., Wenz, F., Sperk, E., Fussl, C., Kaiser, J., … Fastner, G. (2017, January 19). Intraoperative radiotherapy (IORT) as boost in breast cancer. Radiation Oncology (London, England). https://doi.org/10.1186/s13014-016-0749-9

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘2409182736

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 30

60%

Researcher 11

22%

Professor / Associate Prof. 6

12%

Lecturer / Post doc 3

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 48

72%

Nursing and Health Professions 8

12%

Physics and Astronomy 7

10%

Biochemistry, Genetics and Molecular Bi... 4

6%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free
0